Article Figures & Data
Tables
- Table 1.
RA-related comorbidities as potential predictors of healthcare expenditure and work-related outcomes.
Condition ICD-9-CM Codes Asthma 493 Cancer 140–239 Chronic obstructive pulmonary disease 491, 492, 496 Depression 311 Diabetes 250 Disorders of the eye and adnexa 360–379 Disorders of lipid metabolism 272 Heart failure 428 Hypertension 401 Myocardial infarction 410, 412 Osteoporosis 733 Peptic ulcer 531, 532, 533, 534 Stroke 430, 431, 432, 433, 434, 436, 437, 438 ICD-9-CM: International Classification of Diseases, 9th revision, Clinical Modification; RA: rheumatoid arthritis.
Unweighted Weightedb Sex Female 3454 (69.6) 3.0 (64.9) Male 1513 (30.4) 1.6 (35.1) Age, yrs, mean (SD) 59.8 (14.5) 60.9 (15.2) Age, yrs 18–24 53 (1.1) 0.059 (1.3) 25–34 212 (4.3) 0.17 (3.7) 35–44 462 (9.3) 0.40 (8.6) 45–54 1046 (21.1) 0.92 (19.8) 55–64 1305 (26.3) 1.2 (24.8) > 64 1889 (38.0) 2.0 (41.9) Region Northeast 712 (14.3) 0.76 (16.3) Midwest 948 (19.1) 0.98 (21.0) South 2174 (43.8) 1.9 (41.8) West 1133 (22.8) 0.97 (20.9) Marital status Married 2290 (46.1) 2.4 (50.5) Unmarried 2677 (53.9) 2.3 (49.5) Race/ethnicity White 2259 (45.5) 3.1 (67.2) Black 1330 (26.8) 0.68 (14.6) Hispanic 535 (10.8) 0.28 (6.0) Other 843 (17.0) 0.57 (12.3) Family income level Poor/negative 1312 (26.4) 0.86 (18.6) Near poor 483 (9.7) 0.37 (8.0) Low income 897 (18.1) 0.79 (16.9) Middle income 1283 (25.8) 1.3 (28.9) High income 992 (20.0) 1.3 (27.6) Insurance coverage Uninsured 551 (11.1) 0.42 (9.0) Any private 2124 (42.8) 2.4 (51.7) Public only 2292 (46.1) 1.8 (39.2) Education High school not completed 1621 (32.6) 1.2 (25.3) High school completed 1883 (37.9) 1.8 (39.5) Bachelor’s degree 415 (8.4) 0.49 (10.5) Postgraduate 213 (4.3) 0.27 (5.9) Other degree 835 (16.8) 0.88 (18.9) Smoking status Nonsmoker 3835 (77.2) 3.6 (77.0) Smoker 1132 (22.8) 1.1 (23.0) Comorbid conditionsc Hypertension 3166 (63.7) 2.9 (62.2) Lipid metabolism disorders 2316 (46.6) 2.2 (47.3) Diabetes 1379 (27.8) 1.2 (25.1) Depression 1009 (20.3) 0.93 (20.0) Eye and adnexa disorders 837 (16.8) 0.84 (18.1) Asthma 827 (16.6) 0.69 (14.8) COPD 654 (13.2) 0.62 (13.3) Cancer 595 (12.0) 0.68 (14.7) Myocardial infarction 402 (8.1) 0.41 (8.8) Osteoporosis 346 (7.0) 0.34 (7.3) Stroke 298 (6.0) 0.29 (6.2) Heart failure 156 (3.1) 0.14 (3.0) Peptic ulcer 67 (1.3) 0.056 (1.2) No comorbid conditions 724 (14.6) 0.68 (14.6) Number of comorbid conditions, mean (SD) 2.4 (1.7) 2.4 (1.8) Year 2006–2007 416 (8.4) 0.42 (9.1) 2008–2009 1086 (21.9) 1.0 (22.3) 2010–2011 1096 (22.1) 1.0 (22.5) 2012–2013 1200 (24.2) 1.1 (23.1) 2014–2015 1169 (23.5) 1.1 (22.9) Values are expressed as n (%) unless otherwise indicated.
↵a The sample patient population was 4967, representing approximately 4.68 million US adult RA patients.
↵b Number of patients are in millions.
↵c Comorbidities were selected based on a prevalence of > 1%.
COPD: chronic obstructive pulmonary disease; RA: rheumatoid arthritis.
- Table 3.
Multivariable GLM results for total annual healthcare expenditure in patients with RA.
Mean Ratio, (95% CI)a Mean Difference, 2015 US$ (95% CI)b Hypertension 1.23 (1.06–1.43)* 2343 (605–4079)* Lipid metabolism disorders 0.95 (0.83–1.09) 535 (−1993 to 923) Diabetes 1.24 (1.08–1.43)* 2603 (813–4393)* Depression 1.40 (1.21–1.61)** 4235 (2167–6301)** Eye and adnexa disorders 1.22 (1.05–1.42)* 2407 (440–4373)* Asthma 1.09 (0.92–1.28) 968 (−961 to 2896) COPD 1.46 (1.26–1.69)** 4972 (2633–7311)** Cancer 1.32 (1.13–1.53)** 3372 (1322–5423)* Myocardial infarction 1.60 (1.27–2.01)** 6511 (2699–10,323)* Osteoporosis 1.27 (1.05–1.53)* 2925 (318–5531)* Stroke 1.47 (1.19–1.82)** 5150 (1764–8536)* Heart failure 1.75 (1.38–2.22)** 8205 (3683–12,726)** Sex (ref: male) Female 1.13 (0.99–1.30) Age 1.00 (0.99–1.01) Region (ref: West) Northeast 1.19 (0.97–1.46) Midwest 1.26 (1.03–1.55)* South 1.06 (0.90–1.25) Insurance coverage (ref: public only) Any private 0.97 (0.84–1.13) No insurance 0.52 (0.43–0.62)** Education (ref: high school not completed) High school completed 1.07 (0.93–1.24) Bachelor degree 1.56 (1.21–2.01)* Postgraduate degree 1.36 (0.98–1.89) Other degree 1.33 (1.12–1.59)* Smoking status (ref: nonsmoker) Smoker 0.80 (0.67–0.95)* ↵a Values are the exponential form of the β coefficients for a covariate, which represents the multiplier factor for the outcome when the covariate increases by 1; the reference for each comorbidity is absence of the condition.
↵b Values are the average marginal effect for a comorbidity compared to absence of the condition, holding all other covariates at the average values.
↵* P < 0.05.
↵** P < 0.001.
COPD: chronic obstructive pulmonary disease; GLM: generalized linear model; RA: rheumatoid arthritis.
- Table 4.
Multivariable logistic regression results for employment status in patients of working age (18–64 yrs) with RA.
OR (95% CI)a Hypertension 0.69 (0.51–0.92)* Lipid metabolism disorders 1.01 (0.78–1.32) Diabetes 0.85 (0.61–1.18) Depression 0.47 (0.34–0.63)** Eye and adnexa disorders 0.83 (0.54–1.27) Asthma 1.06 (0.72–1.54) COPD 0.53 (0.35–0.82)* Cancer 0.46 (0.27–0.79)* Myocardial infarction 0.60 (0.36–1.01) Osteoporosis 0.55 (0.30–0.99)* Stroke 0.48 (0.26–0.89)* Heart failure 0.08 (0.02–0.29)** Peptic ulcer 0.74 (0.19–2.78) Sex (ref: male) Female 0.70 (0.52–0.95)* Age 0.98 (0.96–0.99)* Marital status (ref: unmarried) Married 0.78 (0.59–1.04) Race/ethnicity (ref: White) Black 0.86 (0.63–1.17) Hispanic 1.27 (0.87–1.87) Other 0.89 (0.62–1.29) Insurance coverage (ref: public only) Any private 10.35 (7.35–14.57)** No insurance 3.43 (2.30–5.123 Education (ref: high school not completed) High school completed 1.43 (1.01–2.03)* Bachelor degree 2.46 (1.37–4.42)* Postgraduate degree 2.56 (1.36–4.83)* Other degree 1.79 (1.20–2.67)* Smoking status (ref: nonsmoker) Smoker 0.91 (0.66–1.26) ↵a The OR is the exponential form of the β coefficient, which represents the multiplier factor for the odds of being employed when the covariate increases by 1; the reference for each comorbidity is the absence of the condition.
↵* P < 0.05.
↵** P < 0.001.
COPD: chronic obstructive pulmonary disease; RA: rheumatoid arthritis.
- Table 5.
Multivariable zero-inflated negative binomial regression results for absenteeism in employed patients of working age (18–64 yrs) with RA.
Zero-inflation Component OR (95% CI)a Count Component IRR (95% CI)b Hypertension 0.38 (0.12–1.19) 1.30 (1.00–1.69)* Lipid metabolism disorders 0.42 (0.10-1.70) 0.83 (0.62–1.11) Diabetes 2.96 (0.59–14.95) 1.08 (0.77–1.51) Depression 1.14 (0.35–3.72) 1.44 (1.05–1.97)* Eye and adnexa disorders 0.25 (0.03–2.02) 1.51 (1.03–2.21)* Asthma 0.00 (0.00–0.00) 1.19 (0.86–1.64) COPD 0.00 (0.00–0.00) 1.40 (0.92–2.15) Cancer 0.86 (0.22–3.27) 1.39 (0.88–2.21) Myocardial infarction < 0.001 (< 0.001 to > 1,000)c 1.06 (0.58–1.93) Osteoporosis < 0.001 (< 0.001 to > 1,000)c 0.61 (0.35–1.08) Stroke 1.93 (0.17–21.40) 2.15 (1.03–4.47)* Heart failure < 0.001 (< 0.001 to > 1,000)c 0.86 (0.20–3.80) Peptic ulcer < 0.001 (< 0.001 to > 1,000)c 0.52 (0.10–2.73) Sex (ref: male) Female 1.01 (0.43–2.37) 1.11 (0.85–1.45) Age 1.11 (1.04–1.19)* 1.00 (0.99–1.01) Region (ref: West) Northeast 0.59 (0.16–2.21) 1.05 (0.71–1.55) Midwest 0.81 (0.26–2.52) 1.40 (1.00–1.97)* South 0.65 (0.23–1.86) 1.25 (0.89–1.76) Marital status (ref: unmarried) Married 4.70 (1.40–15.73)* 1.23 (0.97–1.56) Race/ethnicity (ref: White) Black 0.20 (0.02–1.84) 1.07 (0.77–1.49) Hispanic 0.38 (0.11–1.28) 0.78 (0.53–1.16) Other 0.52 (0.17–1.64) 0.80 (0.57–1.13) Income level (ref: poor/negative) Near poor 0.12 (0.00–8.89) 1.12 (0.63–1.99) Low income 0.20 (0.03–1.29) 0.92 (0.60–1.40) Middle income 0.42 (0.10–1.83) 0.77 (0.51–1.18) High income 0.38 (0.08–1.78) 0.63 (0.40–0.98)* Insurance coverage (ref: public only) Any private 0.30 (0.06–1.41) 1.19 (0.82–1.71) No insurance 2.42 (0.56–10.39) 0.88 (0.57–1.36) Education (ref: high school not completed) High school completed 1.57 (0.40–6.18) 0.93 (0.67–1.29) Bachelor degree 0.68 (0.12–4.01) 0.71 (0.45–1.10) Postgraduate degree 3.37 (0.43–26.66) 1.15 (0.65–2.04) Other degree 1.30 (0.23–7.28) 1.16 (0.79–1.70) Smoking status (ref: nonsmoker) Smoker < 0.001 (< 0.001 to > 1,000)c 0.85 (0.65–1.12) ↵a The OR is the exponential form of the β coefficient, which represents the multiplier factor for the odds of having undetected sick leave when the covariate increases by 1; the reference for each comorbidity is absence of condition.
↵b The IRR is the exponential form of the b coefficient, which represents the multiplier factor for the expected days of sick leave when the covariate increases by 1; the reference for each comorbidity is absence of condition.
↵c Very small positive values of OR and lower limit of the 95% CI, and very large value of the upper limit of the 95% CI.
↵* P < 0.05.
COPD: chronic obstructive pulmonary disease; IRR: incidence rate ratio; RA: rheumatoid arthritis.
Mean Ratio, (95% CI)a Mean Difference, 2015 US$ (95% CI)b Diabetes 0.85 (0.75–0.96)* −5816 (−10,218 to -1415)* Asthma 1.03 (0.83–1.27) 1027 (−7615 to 9670) COPD 0.71 (0.59–0.85)** −11,437 (−16,899 to -5977)** Heart failure 0.59 (0.36–0.97)* −15,833 (−27,231 to -4435)* Peptic ulcer 0.83 (0.49–1.39) −6799 (−23,629 to 10,029) Sex (male as reference) Female 0.75 (0.67–0.84)** Marital status (ref: unmarried) Married 1.01 (0.89–1.15) Insurance coverage (ref: public only) Any private 2.05 (1.70–2.47)** No insurance 1.11 (0.87–1.42) Education (ref: high school not completed) High school completed 1.07 (0.87–1.31) Bachelor degree 1.82 (1.43–2.31)** Postgraduate degree 1.92 (1.46–2.53)** Other degree 1.36 (1.07–1.73)* Smoking status (ref: nonsmoker) Smoker 0.92 (0.81–1.04) ↵a Values are the exponential form of the β coefficients for a covariate, which represents the multiplier factor for the outcome in patients with the comorbid condition or certain level of a categorical variable compared to the reference; the reference for each comorbidity is absence of the condition.
↵b Values are the average marginal effect for a comorbidity compared to absence of the condition, holding all other covariates at the average values.
↵* P < 0.05.
↵** P < 0.001.
COPD: chronic obstructive pulmonary disease; GLM: generalized linear model; RA: rheumatoid arthritis.
Additional Files
200231 Video Abstract
Files in this Data Supplement: